Protokylol hydrochloride
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 412459

CAS#: 136-69-6 (HCl)

Description: Protokylol hydrochloride is the salt form of Protokylol (free base) (Asmetil, Caytine, Palison, Ventaire), a β-adrenergic receptor agonist used as a bronchodilator in Europe and the United States. It is methylenedioxyphenyl-isoproterenol.


Chemical Structure

img
Protokylol hydrochloride
CAS# 136-69-6 (HCl)

Theoretical Analysis

MedKoo Cat#: 412459
Name: Protokylol hydrochloride
CAS#: 136-69-6 (HCl)
Chemical Formula: C18H22ClNO5
Exact Mass: 0.00
Molecular Weight: 367.830
Elemental Analysis: C, 58.78; H, 6.03; Cl, 9.64; N, 3.81; O, 21.75

Price and Availability

Size Price Availability Quantity
5mg USD 500 2 Weeks
25mg USD 950 2 Weeks
100mg USD 2050 2 Weeks
Bulk inquiry

Related CAS #: 136-69-6 (HCl)   136-70-9 (free base)  

Synonym: Protokylol hydrochloride; NSC113490; NSC-113490; NSC 113490

IUPAC/Chemical Name: 1,2-Benzenediol, 4-(2-((2-(1,3-benzodioxol-5-yl)-1-methylethyl)amino)-1-hydroxyethyl)-, hydrochloride (9CI)

InChi Key: LOVXREQUMZKFCM-UHFFFAOYSA-N

InChi Code: InChI=1S/C18H21NO5.ClH/c1-11(6-12-2-5-17-18(7-12)24-10-23-17)19-9-16(22)13-3-4-14(20)15(21)8-13;/h2-5,7-8,11,16,19-22H,6,9-10H2,1H3;1H

SMILES Code: OC1=CC=C(C(O)CNC(C)CC2=CC=C(OCO3)C3=C2)C=C1O.[H]Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 367.83 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Decker N, Quennedey MC, Rouot B, Schwartz J, Velly J. Effects of N-aralkyl substitution of beta-agonists on alpha- and beta-adrenoceptor subtypes: pharmacological studies and binding assays. J Pharm Pharmacol. 1982 Feb;34(2):107-12. PubMed PMID: 6121868.

2: Dolphin A, Hamont M, Bockaert J. The resolution of dopamine and beta 1- and beta 2-adrenergic-sensitive adenylate cyclase activities in homogenates of cat cerebellum, hippocampus and cerebral cortex. Brain Res. 1979 Dec 28;179(2):305-17. PubMed PMID: 41616.

3: Pecker F, Duvaldestin P, Berthelot P, Hanoune J. The adenylate cyclase system in human liver: characterization, subcellular distribution and hormonal sensitivity in normal or cirrhotic adult, and in foetal liver. Clin Sci (Lond). 1979 Oct;57(4):313-25. PubMed PMID: 41665.

4: Vauquelin G, Geynet P, Hanoune J, Strosberg AD. Affinity chromatography of the beta-adrenergic receptor from turkey erythrocytes. Eur J Biochem. 1979 Aug 1;98(2):543-56. PubMed PMID: 226363.

5: Aggerbeck M, Guellaën G, Hanoune J. N-Aralkyl substitution increases the affinity of adrenergic drugs for the alpha-adrenoceptor in rat liver. Br J Pharmacol. 1979 Jan;65(1):155-9. PubMed PMID: 216448; PubMed Central PMCID: PMC1668481.

6: René E, Lacombe ML, Guellaen G, Hanoune J. [Alteration of the catecholamine receptor during hepatic malignancy (author's transl)]. Ann Endocrinol (Paris). 1976 Mar-Apr;37(2):85-6. French. PubMed PMID: 188380.

7: Saito H, Shudo I. [Micro-fluorescence method for the determination of isoproterenol, protokylol and alpha-methyl dopa]. Nihon Yakurigaku Zasshi. 1972 Jul;68(4):422-8. Japanese. PubMed PMID: 4676298.

8: Saito H, Shudo I. Time course observation on protokylol distribution in rats following protokylol administration. Jpn J Pharmacol. 1972 Feb;22(1):97-102. PubMed PMID: 4537628.

9: Scriabine A, Rival J, Bellet S, Morgan G Jr, Weyn AS, Nusbaum M. Effect of protokylol on the ventricular rate in dogs with experimental A-V heart block. Am Heart J. 1969 May;77(5):649-52. PubMed PMID: 5778054.

10: Chahl LA, O'Donnell SR. The actions of orciprenaline and protokylol on guinea-pig trachea. Br J Pharmacol Chemother. 1968 Jul;33(3):552-9. PubMed PMID: 5728322; PubMed Central PMCID: PMC1570248.

11: KOLLOTZEK H. [CONTRIBUTION ON SYMPTOMATIC THERAPY OF ASTHMA WITH PROTOKYLOL]. Med Klin. 1964 Feb 28;59:345-8. German. PubMed PMID: 14151265.

12: BOTTKE H, GUENTHNER W. [ON THE TREATMENT OF BRONCHIAL OBSTRUCTION. CLINICO-EXPERIMENTAL STUDIES WITH PROTOKYLOL]. Med Welt. 1963 Nov 30;48:2464-9. German. PubMed PMID: 14111042.

13: JACOBI H, KOCH K, SCHLEUSING M. [Contribution to the pharmacology of protokylol]. Ther Ggw. 1963 Feb;102:177-80. German. PubMed PMID: 13964296.

14: JACOBI H, KOCH, SCHLEUSING M. [On the pharmacology of protokylol]. Arzneimittelforschung. 1963 Jan;13:51-6. German. PubMed PMID: 13964297.

15: SARTORELLI E, GRIECO A, MANCOSU M. [Effects of caytine on the respiratory function of asthmatic and emphysematous patients]. Gaz Med Port. 1961 Mar-Apr;14:293-4. Portuguese. PubMed PMID: 14497285.

16: SARTORELLI E, GRIECO A, MANCOSU M. [Effects of caytine on ventilatory function of asthmatics and emphysematous patients]. Clin Ter. 1960 May;18:491-3. Italian. PubMed PMID: 14441828.

17: LESLIE A, SIMMONS DH. Evaluation of the bronchodilator, caytine (JB-251). Am J Med Sci. 1957 Sep;234(3):321-4. PubMed PMID: 13458194.

18: SETTEL E. A new broncholytic drug; JB-251 (caytine). Am Pract Dig Treat. 1957 Aug;8(8):1249-51. PubMed PMID: 13444611.